Results 11 to 20 of about 28,367 (174)

Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. [PDF]

open access: yesPLoS ONE, 2013
Here we present mumps virus specific antibody levels in a large cross-sectional population-based serosurveillance study performed in the Netherlands in 2006/2007 (n = 7900).
Gaby Smits   +8 more
doaj   +1 more source

Establishing a small animal model for evaluating protective immunity against mumps virus. [PDF]

open access: yesPLoS ONE, 2017
Although mumps vaccines have been used for several decades, protective immune correlates have not been defined. Recently, mumps outbreaks have occurred in vaccinated populations.
Adrian Pickar   +6 more
doaj   +1 more source

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults

open access: yesVaccines, 2022
Mumps outbreaks and breakthrough infections of measles and rubella have raised concerns about waning of vaccine-induced immunity after two doses of measles-mumps-rubella (MMR) vaccination.
Patricia Kaaijk   +7 more
doaj   +1 more source

Recombinant mumps virus as a cancer therapeutic agent

open access: yesMolecular Therapy: Oncolytics, 2016
Mumps virus belongs to the family of Paramyxoviridae and has the potential to be an oncolytic agent. Mumps virus Urabe strain had been tested in the clinical setting as a treatment for human cancer four decades ago in Japan.
Arun Ammayappan   +2 more
doaj   +1 more source

Easy and Rapid Detection of Mumps Virus by Live Fluorescent Visualization of Virus-Infected Cells. [PDF]

open access: yesPLoS ONE, 2015
Mumps viruses show diverse cytopathic effects (CPEs) of infected cells and viral plaque formation (no CPE or no plaque formation in some cases) depending on the viral strain, highlighting the difficulty in mumps laboratory studies. In our previous study,
Tadanobu Takahashi   +13 more
doaj   +1 more source

A new method for the detection of neutralizing antibodies against mumps virus. [PDF]

open access: yesPLoS ONE, 2013
Neutralization test is the most reliable method of evaluating immunity against viral diseases but there is no standard procedure for mumps virus, with tests differing in the infectivity of the challenge virus, 50% plaque reduction or complete inhibition ...
Keita Matsubara   +4 more
doaj   +1 more source

Mumps Orchitis: Clinical Aspects and Mechanisms

open access: yesFrontiers in Immunology, 2021
The causative agent of mumps is a single-stranded, non-segmented, negative sense RNA virus belonging to the Paramyxoviridae family. Besides the classic symptom of painfully swollen parotid salivary glands (parotitis) in mumps virus (MuV)-infected men ...
Han Wu   +4 more
doaj   +1 more source

Molecular epidemiology of mumps viruses in the Netherlands, 2017-2019

open access: yesPLoS ONE, 2020
Mumps cases continue to occur, also in countries with a relatively high vaccination rate. The last major outbreaks of mumps in the Netherlands were in 2009–2012 and thereafter, only small clusters and single cases were reported.
Rogier Bodewes   +7 more
doaj   +2 more sources

Mumps, Cervical Zoster, and Facial Paralysis: Coincidence or Association?

open access: yesCase Reports in Otolaryngology, 2014
The association of mumps with peripheral facial paralysis has been suggested, but its pathogenesis remains unclear. An 8-year-old girl simultaneously developed left peripheral facial paralysis, ipsilateral cervical herpes zoster, and bilateral mumps ...
Kenji Kondo   +3 more
doaj   +1 more source

Functional Characterization of Circulating Mumps Viruses with Stop Codon Mutations in the Small Hydrophobic Protein

open access: yesmSphere, 2020
Between 2015 and 2017, routine molecular surveillance in the United States detected multiple mumps viruses (MuVs) with mutations in the small hydrophobic (SH) gene compared to a reference virus of the same genotype.
Rita Czakó Stinnett   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy